CILETATUG VEDOTIN
UNII 7ER98K4WW9

Substance Identification & Data

This profile provides standardized clinical and technical data for Ciletatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7ER98K4WW9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2897624-59-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7ER98K4WW9
CAS Registry Number
2897624-59-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CILETATUG VEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C180906
National Cancer Institute reference terminology for clinical and research data.
INN ID
13111
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ciletatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CILETATUG VEDOTIN
CILETATUG VEDOTIN [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN/MACACA FASCICULARIS/MUS MUSCULUS/CANIS FAMILIARIS/RATTUS NORVEGICUS CLAUDIN CLDN18.2) (HUMAN-MUS MUSCULUS MONOCLONAL RC118-B186314B11S .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL RC118-B186314B11S .KAPPA.-CHAIN, DIMER, 220'',220''',222,222',228,228',231,231'-OCTAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO VEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE) (CILETATUG VEDOTIN)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus